Filing Details

Accession Number:
0000919574-21-004135
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-21 08:28:47
Reporting Period:
2021-06-16
Accepted Time:
2021-06-21 08:28:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
718937 Staar Surgical Co STAA Ophthalmic Goods (3851) 953797439
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278386 Broadwood Partners, L.p. C/O Broadwood Capital Inc.
142 West 57Th Street, 11Th Floor
New York NY 10019
No No Yes No
1278387 Broadwood Capital Inc 142 West 57Th Street, 11Th Floor
New York NY 10019
No No Yes No
1278388 C Neal Bradsher C/O Broadwood Capital Inc.
142 West 57Th Street, 11Th Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-16 30,543 $148.79 8,969,814 No 4 S Direct
Common Stock Disposition 2021-06-16 0 $0.00 8,969,814 No 4 S Indirect See Footnote
Common Stock Disposition 2021-06-17 63,896 $150.31 8,905,918 No 4 S Direct
Common Stock Disposition 2021-06-17 0 $0.00 8,905,918 No 4 S Indirect See Footnote
Common Stock Disposition 2021-06-18 13,236 $152.59 8,892,682 No 4 S Direct
Common Stock Disposition 2021-06-18 0 $0.00 8,892,682 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Direct
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 25,900 Direct
Footnotes
  1. The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  2. This constitutes the weighted average sale price. The prices range from $148.01 to $150.37. The Reporting Persons will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. This constitutes the weighted average sale price. The prices range from $148.25 to $151.91. The Reporting Persons will provide upon request by the SEC Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. This constitutes the weighted average sale price. The prices range from $151.04 to $154.48. The Reporting Persons will provide upon request by the SEC Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. These securities are directly owned by Neal C. Bradsher.